红人参的保护作用 抗质诱导的肝毒性:与网络药理学和实验验证的综合方法
Bong-Jo Kim1, Seon-Been Bak1, Su-Jin Bae1,2
1Department of Korean Medicine, Dongguk University, Gyeongju, 38066, Korea.
Drug design, development and therapy
|February 29, 2024
概括
红人参 (RG) 能保护肝脏免受阿尔茨海默病治疗药物塔克林的损伤. RG减轻氧化应激和亡,提供一种潜在的自然方法来降低药物毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 神经科学是一个神经科学.
背景情况:
- 塔克林是一种FDA批准的乙胆酶抑制剂,对阿尔茨海默病有效,但会导致肝毒性.
- 氧化应激是结体诱导的肝损伤的一个关键因素.
研究的目的:
- 为了研究红人参 (RG) 保护性作用,以防止肌诱导的肝毒性.
- 阐明RG的保护作用背后的机制,重点关注氧化应激和亡.
主要方法:
- 网络分析以确定参与氧化性肝损伤的RG目标.
- 在体外测试 (MTT,FACS,免疫阻塞) 来评估RG对亡和线粒体功能的影响.
- 在小鼠体内进行的研究,以评估RG的保护作用,以防止肌诱导的肝损伤.
主要成果:
- 网络分析确定了AMPK通路内的RG目标,这对于氧化性肝损伤至关重要.
- 在体外,RG (1000μg/mL) 减轻了质诱导的亡和线粒体损伤.
- RG激活了LKB1介导的AMPK通路和Hippo-Yap信号传递.
- 在小鼠中,RG证明了与西利马林相比的肝脏保护.
结论:
- 红人参表现出显著的保护作用,可以防止克林诱导的肝毒性.
- RG的机制涉及调节氧化应激,亡和关键信号通路,如AMPK.
- 像RG这样的天然产品可能提供一种减少阿尔茨海默病治疗毒性的策略.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
相关概念视频
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
